I. S. Idilman Et Al. , "The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study," CLINICAL RADIOLOGY , vol.76, no.9, 2021
Idilman, I. S. Et Al. 2021. The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study. CLINICAL RADIOLOGY , vol.76, no.9 .
Idilman, I. S., Celik, A., Savas, B., Idilman, R., & Karcaaltincaba, M., (2021). The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study. CLINICAL RADIOLOGY , vol.76, no.9.
Idilman, I. Et Al. "The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study," CLINICAL RADIOLOGY , vol.76, no.9, 2021
Idilman, I. S. Et Al. "The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study." CLINICAL RADIOLOGY , vol.76, no.9, 2021
Idilman, I. S. Et Al. (2021) . "The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study." CLINICAL RADIOLOGY , vol.76, no.9.
@article{article, author={I. S. Idilman Et Al. }, title={The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study}, journal={CLINICAL RADIOLOGY}, year=2021}